Apheris
Berlin
About Apheris
Apheris delivers enterprise-grade AI applications for drug discovery, designed for pharma companies to run and customize securely within their own IT environments. By keeping all data local, organizations maintain full sovereignty over IP-sensitive assets. These local deployments also serve as the foundation for Apheris-hosted federated data networks (based on Federated Learning technology), where pharma companies collaboratively train and benchmark models on proprietary datasets to unlock more robust and generalizable models for drug discovery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $32.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: apheris.com
- Phone: +49 176 57864816
Industries & Categories
Analytics, Artificial Intelligence (AI), Machine Learning, Network Security
Social Profiles
Canonical: https://fsome.com/organization/apheris-63950 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.